|
ARMC8 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.298200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.219000E-01 |
| Normal-vs-Stage2 |
9.311000E-01 |
| Normal-vs-Stage3 |
6.136800E-01 |
| Normal-vs-Stage4 |
3.570000E-01 |
| Stage1-vs-Stage2 |
5.633400E-01 |
| Stage1-vs-Stage3 |
9.924000E-01 |
| Stage1-vs-Stage4 |
3.537400E-01 |
| Stage2-vs-Stage3 |
6.598400E-01 |
| Stage2-vs-Stage4 |
3.575600E-01 |
| Stage3-vs-Stage4 |
3.538200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.269400E-01 |
| Normal-vs-AfricanAmerican |
3.719000E-01 |
| Normal-vs-Asian |
4.508400E-01 |
| Caucasian-vs-AfricanAmerican |
2.642000E-01 |
| Caucasian-vs-Asian |
2.661200E-01 |
| AfricanAmerican-vs-Asian |
9.240400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.561800E-01 |
| Normal-vs-Female |
3.845000E-01 |
| Male-vs-Female |
4.476000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.596200E-02 |
| Normal-vs-Extreme_Weight |
1.245430E-01 |
| Normal-vs-Obese |
8.131600E-01 |
| Normal-vs-Extreme_Obese |
9.027000E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.928000E-01 |
| Normal_Weight-vs-Obese |
1.702380E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.078400E-01 |
| Extreme_Weight-vs-Obese |
2.718000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.382400E-01 |
| Obese-vs-Extreme_Obese |
9.553600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.967400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.966200E-01 |
| Normal-vs-Age(61-80Yrs) |
4.181600E-01 |
| Normal-vs-Age(81-100Yrs) |
8.414100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.446600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.218380E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.379800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.689600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.980640E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.233200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.839600E-01 |
| Normal-VS-Type2 PRCC |
3.896400E-01 |
| Normal-VS-KIRP CIMP |
7.784800E-01 |
| Normal-VS-Unclassified PRCC |
5.129400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.147200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.927800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.613800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.804200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.256200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.045400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.751600E-01 |
| Normal-vs-N1 |
8.993400E-01 |
| Normal-vs-N2 |
1.478210E-03 |
| N0-vs-N1 |
3.802200E-01 |
| N0-vs-N2 |
2.609800E-01 |
| N1-vs-N2 |
1.073760E-01 |
|
|
